These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Phosphatidylcholine hydrolysis by phospholipase D determines phosphatidate and diglyceride levels in chemotactic peptide-stimulated human neutrophils. Involvement of phosphatidate phosphohydrolase in signal transduction. Billah MM, Eckel S, Mullmann TJ, Egan RW, Siegel MI. J Biol Chem; 1989 Oct 15; 264(29):17069-77. PubMed ID: 2793844 [Abstract] [Full Text] [Related]
3. Role of Ca2+ in phosphatidylinositol response and arachidonic acid release in formylated tripeptide- or Ca2+ ionophore A23187-stimulated guinea pig neutrophils. Takenawa T, Homma Y, Nagai Y. J Immunol; 1983 Jun 15; 130(6):2849-55. PubMed ID: 6406597 [Abstract] [Full Text] [Related]
5. Platelet-activating factor stimulates the phosphatidylinositol cycle. Appearance of phosphatidic acid is associated with the release of serotonin in horse platelets. Lapetina EG. J Biol Chem; 1982 Jul 10; 257(13):7314-7. PubMed ID: 7045103 [Abstract] [Full Text] [Related]
6. Complement receptor-mediated phagocytosis is associated with accumulation of phosphatidylcholine-derived diglyceride in human neutrophils. Involvement of phospholipase D and direct evidence for a positive feedback signal of protein kinase. Fällman M, Gullberg M, Hellberg C, Andersson T. J Biol Chem; 1992 Feb 05; 267(4):2656-63. PubMed ID: 1733962 [Abstract] [Full Text] [Related]
7. Evidence that increasing the cellular content of eicosapentaenoic acid does not reduce the biosynthesis of platelet-activating factor. Triggiani M, Connell TR, Chilton FH. J Immunol; 1990 Oct 01; 145(7):2241-8. PubMed ID: 2118931 [Abstract] [Full Text] [Related]
8. Phospholipid remodeling in human neutrophils. Parallel activation of a deacylation/reacylation cycle and platelet-activating factor synthesis. Reinhold SL, Zimmerman GA, Prescott SM, McIntyre TM. J Biol Chem; 1989 Dec 25; 264(36):21652-9. PubMed ID: 2513324 [Abstract] [Full Text] [Related]
9. Tumor necrosis factor-alpha priming of phospholipase A2 activation in human neutrophils. An alternative mechanism of priming. Bauldry SA, McCall CE, Cousart SL, Bass DA. J Immunol; 1991 Feb 15; 146(4):1277-85. PubMed ID: 1846897 [Abstract] [Full Text] [Related]
11. Epidermal growth factor induces the production of biologically distinguishable diglyceride species from phosphatidylinositol and phosphatidylcholine via the independent activation of type C and type D phospholipases. Song J, Jiang YW, Foster DA. Cell Growth Differ; 1994 Jan 15; 5(1):79-85. PubMed ID: 8123595 [Abstract] [Full Text] [Related]
17. The relative degradation of [14C]eicosapentaenoyl and [3H]arachidonoyl species of phosphatidylinositol and phosphatidylcholine in thrombin-stimulated human platelets. Weaver BJ, Holub BJ. Biochem Cell Biol; 1986 Dec 15; 64(12):1256-61. PubMed ID: 3032217 [Abstract] [Full Text] [Related]
18. Complement C5a activation of phospholipase D in human neutrophils. A major route to the production of phosphatidates and diglycerides. Mullmann TJ, Siegel MI, Egan RW, Billah MM. J Immunol; 1990 Mar 01; 144(5):1901-8. PubMed ID: 2307846 [Abstract] [Full Text] [Related]
19. Mechanism of arachidonic acid release in human polymorphonuclear leukocytes. Walsh CE, Dechatelet LR, Chilton FH, Wykle RL, Waite M. Biochim Biophys Acta; 1983 Jan 07; 750(1):32-40. PubMed ID: 6402027 [Abstract] [Full Text] [Related]
20. Rapid acylation and deacylation of arachidonic acid into phosphatidic acid of horse neutrophils. Lapetina EG, Billah MM, Cuatrecasas P. J Biol Chem; 1980 Nov 25; 255(22):10966-70. PubMed ID: 6776123 [Abstract] [Full Text] [Related] Page: [Next] [New Search]